-
WuXi Biologics, I-Mab Biopharma Ink Long-term Strategic Pact
contractpharma
April 17, 2019
WuXi to provide CMC development and commercial manufacturing.
-
WuXi NextCODE expands laboratory footprint into the U.S.
biospectrumasia
April 02, 2019
WuXi NextCODE launches new state-of-the-art genetic analysis laboratory in U.S. with Illumina's New TruSight 500™ Assay
-
WuXi Healthcare forum 2019 starts in Shanghai
biospectrumasia
March 05, 2019
The forum attracts application of more than 5,000 industry leaders from 2,000 enterprises and organizations, spanning 20 countries
-
WuXi Biologics Advances Cell Culture Productivity
contractpharma
December 13, 2018
WuXi Biologics has advanced cell culture productivity for an Fc-fusion protein. The cell culture has a productivity of 2.5g/L/day and 51g/L bioreactor volume in a 20-day continuous cell culture process called WuXiUP (Ultra-high Productivity).
-
Tech platform company WuXi Biologics inks deal with cancer specialist Oxford BioTherapeutics worth $450m
pharmafile
December 13, 2018
Clinical stage oncology firm Oxford BioTherapeutics has signed a deal with the open-access biologics technology platform company WuXi Biologics, in a deal worth more than $450 million.
-
WuXi Biologics Begins Construction of New Facility
contractpharma
November 27, 2018
WuXi Biologics said that construction of a global innovation center has commenced in the district of Fengxian in Shanghai, China.
-
CASI To Build GMP Mfg. Site In Wuxi, China
contractpharma
November 19, 2018
CASI Pharmaceuticals has entered into agreements to build a state-of-the-art manufacturing site in the Wuxi Huishan Econ
-
Schrödinger, WuXi AppTec Enter Drug Discovery Tie-up
contractpharma
November 12, 2018
Schrödinger, WuXi AppTec Enter Drug Discovery Tie-up
-
WuXi Biologics to Build New Biologics Center
contractpharma
November 01, 2018
WuXi Biologics to Build New Biologics Center
-
WuXi PharmaTech partners with Pharmacyclics
biospectrumasia
October 29, 2018
WuXi PharmaTech partners with Pharmacyclics